Hong Kong · Delayed Price · Currency is HKD Rainmed Medical Statistics
Total Valuation
Rainmed Medical has a market cap or net worth of HKD 227.02 million. The enterprise value is 287.64 million.
| Market Cap | 227.02M |
| Enterprise Value | 287.64M |
Important Dates
The next estimated earnings date is Tuesday, December 1, 2026.
| Earnings Date | Dec 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Rainmed Medical has 1.40 billion shares outstanding. The number of shares has increased by 14.76% in one year.
| Current Share Class | 1.40B |
| Shares Outstanding | 1.40B |
| Shares Change (YoY) | +14.76% |
| Shares Change (QoQ) | -7.93% |
| Owned by Insiders (%) | 47.48% |
| Owned by Institutions (%) | 8.27% |
| Float | 524.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.28 |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.55.
| Current Ratio | 2.43 |
| Quick Ratio | 2.20 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.86 |
| Interest Coverage | -77.97 |
Financial Efficiency
Return on equity (ROE) is -18.75% and return on invested capital (ROIC) is -8.15%.
| Return on Equity (ROE) | -18.75% |
| Return on Assets (ROA) | -7.24% |
| Return on Invested Capital (ROIC) | -8.15% |
| Return on Capital Employed (ROCE) | -12.75% |
| Weighted Average Cost of Capital (WACC) | 4.17% |
| Revenue Per Employee | 130,117 |
| Profits Per Employee | -371,335 |
| Employee Count | 208 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.75 |
Taxes
| Income Tax | -53,106 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.62% in the last 52 weeks. The beta is 0.64, so Rainmed Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -53.62% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 44.08 |
| Average Volume (20 Days) | 294,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rainmed Medical had revenue of HKD 27.06 million and -77.24 million in losses. Loss per share was -0.06.
| Revenue | 27.06M |
| Gross Profit | 15.24M |
| Operating Income | -71.74M |
| Pretax Income | -79.85M |
| Net Income | -77.24M |
| EBITDA | -71.70M |
| EBIT | -71.74M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 148.97 million in cash and 210.08 million in debt, with a net cash position of -61.11 million or -0.04 per share.
| Cash & Cash Equivalents | 148.97M |
| Total Debt | 210.08M |
| Net Cash | -61.11M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | 380.86M |
| Book Value Per Share | 0.27 |
| Working Capital | 134.77M |
Cash Flow
In the last 12 months, operating cash flow was -59.16 million and capital expenditures -184.90 million, giving a free cash flow of -244.06 million.
| Operating Cash Flow | -59.16M |
| Capital Expenditures | -184.90M |
| Depreciation & Amortization | 37,454 |
| Net Borrowing | 173.09M |
| Free Cash Flow | -244.06M |
| FCF Per Share | -0.17 |
Margins
Gross margin is 56.31%, with operating and profit margins of -265.06% and -285.39%.
| Gross Margin | 56.31% |
| Operating Margin | -265.06% |
| Pretax Margin | -295.04% |
| Profit Margin | -285.39% |
| EBITDA Margin | -264.93% |
| EBIT Margin | -265.06% |
| FCF Margin | n/a |
Dividends & Yields
Rainmed Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -14.76% |
| Shareholder Yield | -14.76% |
| Earnings Yield | -34.45% |
| FCF Yield | -108.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Rainmed Medical has an Altman Z-Score of -5.45 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.45 |
| Piotroski F-Score | 3 |